# Paras Healthcare Rs 1,450 crore IPO opens, GMP at Rs 50 to 55 per share 2026-10-21T07:42:12+00:00 | Governance | Indian Opinion Desk Corroboration: 4 independent outlets Paras Healthcare Ltd’s Rs 1,450 crore initial public offering opened for subscription on Wednesday, 21 October, and will close on Friday, 23 October. The price band is Rs 660 to Rs 693 per share, with a lot size of 21 shares, requiring a minimum retail investment of Rs 14,553. The issue combines a fresh issue of 72.15 lakh shares (Rs 500 crore) and an offer for sale of 1.37 crore shares (Rs 950 crore). In the grey market, the IPO commands a premium of Rs 50 to Rs 55 per share, or roughly 7 to 8 per cent over the upper price band, The Economic Times and Business Today report. The company raised Rs 652.5 crore from 39 anchor investors on 19 October, including Abu Dhabi Investment Authority, BlackRock, and SBI Mutual Fund. Proceeds of Rs 320.9 crore will prepay debt and Rs 54.1 crore will fund a subsidiary. Allotment is expected on 26 October, with listing on the BSE and NSE on 28 October. Update, 21 October 2026: Livemint now reports the same IPO details as other outlets, Rs 1,450 crore size, price band Rs 660 to 693, anchor investors on 19 October, and adds analysis on the company's financial turnaround: occupancy rose to 61.8 per cent in FY26 from 50.8 per cent in FY25, contributing to a net profit of Rs 44 crore in FY26. The story confirms no changes to the offer size or subscription calendar. ## Indian Opinion Analysis All four outlets report the same basic IPO details: size (Rs 1,450 crore), price band (Rs 660 to 693), anchor allocation (Rs 652.5 crore on 19 October) and listing date (28 October). Coverage is factual and uniform. The only divergence is depth: Livemint adds financial analysis on debt repayment and occupancy as a profit driver, offset by slower collections and expansion costs, while Business Standard quotes SBI Securities' Neutral view flagging regulatory risk. Economic Times and Business Today lead with GMP and listing gains. The consistent takeaway across sources is the story of a turnaround to profit through higher occupancy, with debt reduction as the immediate use of proceeds, but no source disputes the company's ability to deliver on its expansion timeline. ## Coverage Coverage: 4 sources, 4 neutral - economictimes.indiatimes.com (neutral report) Leads with GMP and listing gains, neutral factual report - businesstoday.in (neutral report) Adds brokerage 'Subscribe' view, neutral factual reporting - business-standard.com (neutral report) Cites SBI Securities 'Neutral' rating, balanced analyst quote - livemint.com (neutral report) Deep financial analysis on occupancy and debt, neutral analytical piece This brief was synthesised by AI from the 4 sources linked above, so one read covers every framing they carry. Tags: Abu Dhabi Investment Authority, BlackRock, BSE, IPO, NSE, Paras Healthcare Canonical: https://indianopinion.org/paras-healthcare-ipo-opens-at-rs-1450-crore-gmp-at-7/ License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources. Cite: https://indianopinion.org/paras-healthcare-ipo-opens-at-rs-1450-crore-gmp-at-7/#story-in-brief How this brief was made: an AI model read the reports linked above and wrote this summary and analysis, which were published automatically. Published briefs are sampled every hour by an automated quality check; the editor verifies its findings and approves corrections, and corrected briefs carry a dated correction line. Stance labels are editorial classifications of how each outlet framed this story, assigned by the same model, not ratings of the outlets. We do no original reporting. Methodology: https://indianopinion.org/ai-use-policy/